Knocking down SLIT2, an axon guidance glycoprotein, in orbital fibroblasts of GD patients upregulated the expression of TNF-α and IL-6 [103], which may represent an attractive therapeutic target for TAO. This evidence concerns the gene IL6 and thromboangiitis obliterans.